Healthcare provider profile · identity verified

Elsa Valero, MD

Family Practice · BERWYN, IL · NPI 1033383088

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	1099	379
Lisinopril	Lisinopril	657	202
Metformin Hcl	Metformin Hcl	575	188
Alendronate Sodium	Alendronate Sodium	491	159
Levothyroxine Sodium	Levothyroxine Sodium	379	118
Amlodipine Besylate	Amlodipine Besylate	320	107
Pantoprazole Sodium	Pantoprazole Sodium	317	111
Losartan Potassium	Losartan Potassium	293	97
Gabapentin	Gabapentin	262	109
Omeprazole	Omeprazole	255	86
Rosuvastatin Calcium	Rosuvastatin Calcium	238	82
Hydrochlorothiazide	Hydrochlorothiazide	230	77
Januvia	Sitagliptin Phosphate	213	59
Alprazolam	Alprazolam	205	42
Fenofibrate	Fenofibrate Nanocrystallized	205	73
Escitalopram Oxalate	Escitalopram Oxalate	199	74
Metoprolol Succinate	Metoprolol Succinate	180	65
Jardiance	Empagliflozin	172	49
Furosemide	Furosemide	171	64
Simvastatin	Simvastatin	171	54
Trazodone Hcl	Trazodone Hcl	171	62
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	164	28
Diclofenac Sodium	Diclofenac Sodium	160	60
Ozempic	Semaglutide	157	44
Glipizide Er	Glipizide	153	44
Ibuprofen	Ibuprofen	141	57
Albuterol Sulfate Hfa	Albuterol Sulfate	137	53
Tamsulosin Hcl	Tamsulosin Hcl	137	45
Glipizide	Glipizide	128	43
Fluticasone Propionate	Fluticasone Propionate	107	54
Carvedilol	Carvedilol	106	37
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	106	59
Vitamin D2	Ergocalciferol (Vitamin D2)	99	35
Eliquis	Apixaban	98	25
Pioglitazone Hcl	Pioglitazone Hcl	98	26
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	94	29
Nystatin	Nystatin	84	43
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	79	24
Hydralazine Hcl	Hydralazine Hcl	78	24
Trulicity	Dulaglutide	75	15
Lidocaine	Lidocaine	74	28
Metformin Hcl Er	Metformin Hcl	74	26
Hydroxyzine Hcl	Hydroxyzine Hcl	73	43
Azithromycin	Azithromycin	71	59
Enalapril Maleate	Enalapril Maleate	70	24
Fenofibrate	Fenofibrate	64	23
Montelukast Sodium	Montelukast Sodium	64	23
Zolpidem Tartrate	Zolpidem Tartrate	64	suppressed
Finasteride	Finasteride	63	22
Sertraline Hcl	Sertraline Hcl	63	25
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	62	18
Famotidine	Famotidine	61	26
Lorazepam	Lorazepam	61	12
Tramadol Hcl	Tramadol Hcl	60	22
Nifedipine Er	Nifedipine	56	12
Meclizine Hcl	Meclizine Hcl	55	31
Metoprolol Tartrate	Metoprolol Tartrate	54	24
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	52	42
Celecoxib	Celecoxib	51	16
Donepezil Hcl	Donepezil Hcl	50	13
Ondansetron Hcl	Ondansetron Hcl	50	15
Prednisone	Prednisone	49	43
Clopidogrel	Clopidogrel Bisulfate	47	17
Naproxen	Naproxen	47	15
Triamcinolone Acetonide	Triamcinolone Acetonide	45	28
Breo Ellipta	Fluticasone/Vilanterol	43	12
Farxiga	Dapagliflozin Propanediol	41	18
Solifenacin Succinate	Solifenacin Succinate	41	20
Clonazepam	Clonazepam	40	suppressed
Sildenafil Citrate	Sildenafil Citrate	40	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	39	24
Valacyclovir	Valacyclovir Hcl	39	15
Lovastatin	Lovastatin	38	11
Valsartan	Valsartan	38	11
Benazepril Hcl	Benazepril Hcl	37	11
Hydrocortisone	Hydrocortisone	35	15
Olanzapine	Olanzapine	35	13
Pregabalin	Pregabalin	35	suppressed
Neomycin-Polymyxin-Hc	Neomycin/Polymyxin B/Hydrocort	34	32
Xarelto	Rivaroxaban	33	suppressed
Potassium Chloride	Potassium Chloride	32	14
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	31	suppressed
Mirtazapine	Mirtazapine	31	15
Mometasone Furoate	Mometasone Furoate	31	23
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	31	20
Acetaminophen-Codeine	Acetaminophen With Codeine	30	suppressed
Allopurinol	Allopurinol	30	15
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	30	23
Azelastine Hcl	Azelastine Hcl	30	24
Glimepiride	Glimepiride	30	suppressed
Irbesartan	Irbesartan	30	suppressed
Paroxetine Hcl	Paroxetine Hcl	30	suppressed
Pravastatin Sodium	Pravastatin Sodium	29	suppressed
Tresiba Flextouch U-100	Insulin Degludec	29	suppressed
Buspirone Hcl	Buspirone Hcl	28	suppressed
Duloxetine Hcl	Duloxetine Hcl	28	12
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	26	13
Cephalexin	Cephalexin	25	21
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	25	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	25	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	24	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	24	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	24	suppressed
Torsemide	Torsemide	24	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	24	suppressed
Myrbetriq	Mirabegron	23	11
Meloxicam	Meloxicam	22	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	22	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	21	suppressed
Ketoconazole	Ketoconazole	21	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	21	suppressed
Atenolol	Atenolol	20	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	20	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	20	suppressed
Humalog Kwikpen U-100	Insulin Lispro	20	suppressed
Mounjaro	Tirzepatide	20	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	20	suppressed
Penicillin V Potassium	Penicillin V Potassium	20	20
Tradjenta	Linagliptin	20	suppressed
Trueplus Pen Needle	Pen Needle, Diabetic	20	suppressed
Promethazine Hcl	Promethazine Hcl	19	17
Propranolol Hcl	Propranolol Hcl	19	suppressed
Scopolamine	Scopolamine	19	16
Acyclovir	Acyclovir	18	suppressed
Fluconazole	Fluconazole	18	12
Linzess	Linaclotide	18	suppressed
Polymyxin B Sul-Trimethoprim	Polymyxin B Sulf/Trimethoprim	18	16
Amitriptyline Hcl	Amitriptyline Hcl	17	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	17	suppressed
Entresto	Sacubitril/Valsartan	17	suppressed
Spironolactone	Spironolactone	17	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	17	suppressed
Colchicine	Colchicine	16	suppressed
Ezetimibe	Ezetimibe	16	suppressed
Terbinafine Hcl	Terbinafine Hcl	16	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	16	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	16	suppressed
Amoxicillin	Amoxicillin	15	13
Megestrol Acetate	Megestrol Acetate	15	suppressed
Alcohol Pads	Alcohol Antiseptic Pads	14	suppressed
Clindamycin Hcl	Clindamycin Hcl	14	11
Erythromycin	Erythromycin Base	14	14
Ibandronate Sodium	Ibandronate Sodium	14	suppressed
Methimazole	Methimazole	14	suppressed
Bupropion Xl	Bupropion Hcl	13	suppressed
Diclofenac Sodium-Misoprostol	Diclofenac Sodium/Misoprostol	13	suppressed
Memantine Hcl	Memantine Hcl	13	suppressed
Ondansetron Odt	Ondansetron	13	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	13	suppressed
Pentoxifylline	Pentoxifylline	13	suppressed
Verapamil Er	Verapamil Hcl	13	suppressed
Citalopram Hbr	Citalopram Hydrobromide	12	suppressed
Clotrimazole	Clotrimazole	12	suppressed
Easy Touch Alcohol Prep Pads	Alcohol Antiseptic Pads	12	suppressed
Telmisartan	Telmisartan	12	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	12	suppressed
Dutasteride	Dutasteride	11	suppressed
Levofloxacin	Levofloxacin	11	suppressed
Metronidazole	Metronidazole	11	suppressed
Tizanidine Hcl	Tizanidine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error